Yazar "İnanç, Mevlüde" için listeleme
-
Cisplatin plus paclitaxel and bevacizumab versus carboplatin plus paclitaxel and bevacizumab for the first-line treatment of metastatic or recurrent cervical cancer
İlhan, Yusuf; Tatlı, Ali Murat; Teker, Fatih; Önder, Arif Hakan; Köse, Fatih; Geredeli, Çağlayan; Karaağaç, Mustafa; Kaplan, Muhammet Ali; İnanç, Mevlüde; Göktaş Aydın, Sabin; Kargı, Ayşegül; Arak, Hacı; Özturk, Banu; Beşen, Ali Ayberk; Selvi, Oğuzhan; Korkmaz, Mustafa; Oruç, Zeynep; Bozkurt, Oktay; Bilici, Ahmet; Bayram, Selami; Dae, Shute Ailia; Özdoğan, Mustafa; Coşkun, Hasan Şenol; Sezgin Göksu, Sema (BMJ Publishing Group, 2022)OBJECTIVE: Cisplatin-paclitaxel and bevacizumab is a frequently used treatment regimen for metastatic or recurrent cervical cancer, and carboplatin-paclitaxel and bevacizumab are also among the recommended regimens. In ... -
Clinical and pathologic features of patients with rare ovarian tumors: Multi-center review of 167 patients by the anatolian society of medical oncology
Bilici, Ahmet; İnanç, Mevlüde; Ulaş, Arife; Akman, Tülay; Şeker, Mehmet; Babacan Akgül, Nalan; İnal, Ali; Bal, Öznur; Koral, Lokman; Sevinç, Alper; Tufan, Gülnihal; Elkıran, Emin Tamer; Ustaalioğlu Öven, Bala Başak; Yavuzşen, Tuğba; Alkış, Necati; Özkan, Metin; Gümüş, Mahmut (Asian Pacific Organization for Cancer Prevention, 2013)Background: Non-epithelial malignant ovarian tumors and clear cell carcinomas, Brenner tumors, transitional cell tumors, and carcinoid tumors of the ovary are rare ovarian tumors (ROTs). In this study, our aim was to ... -
The comparison of FOLFOX regimens with different doses of 5-FU for the adjuvant treatment of colorectal cancer: A multicenter study
Akdeniz, Nadiye; Kaplan, Muhammet Ali; Uncu, Doğan; İnanç, Mevlüde; Kaya, Serap; Dane, Faysal; Küçüköner, Mehmet; Demirci, Ayşe; Bilici, Mehmet; Gök Durnalı, Ayşe; Koral, Lokman; Şendur, Mehmet Ali Nahit; Erol, Cihan; Türkmen, Esma; Ölmez, Ömer Fatih; Açıkgöz, Özgür; Laçin, Şahin; Şahinli, Hayriye; Urakçı, Zuhat; Işıkdoğan, Abdurrahman (Springer, 2021)Purpose We aim to compare the efficiency and toxicity of three different 5-fluorouracil (5-FU) administration types in 5-FU, leucovorin, and oxaliplatin (FOLFOX) combination treatment for adjuvant therapy in colorectal ... -
Medication errors in chemotherapy preparation and administration: A survey conducted among oncology nurses in Turkey
Ulaş, Arife; Sılay, Kamile; Akıncı, Sema; Dede, Didem Şener; Akıncı, Muhammed Bülent; Şendur, Mehmet Ali; Çubukçu, Erdem; Çoşkun, Hasan Şenol; Deǧirmenci, Mustafa; Utkan, Güngör Ör; Özdemir, Nuriye Yıldırım; Işıkdoğan, Abdurrahman; Büyükçeli̇k, Abdullah; İnanç, Mevlüde; Bilici, Ahmet Erkan; Odabaşı, Hatice; Cihan, Şener; Avcı, Nilüfer; Yalçın, Bülent (Asian Pacific Organization for Cancer Prevention, 2015)Background: Medication errors in oncology may cause severe clinical problems due to low therapeutic indices and high toxicity of chemotherapeutic agents. We aimed to investigate unintentional medication errors and underlying ...